Topics

Eli Lilly's migraine treatment wins U.S. FDA approval

10:47 EDT 11 Oct 2019 | Reuters

The U.S. Food and Drug Administration said on Friday it had approved Eli Lilly and Co's migraine drug, Reyvow.

Original Article: Eli Lilly's migraine treatment wins U.S. FDA approval

NEXT ARTICLE

More From BioPortfolio on "Eli Lilly's migraine treatment wins U.S. FDA approval"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...